NAICS 325414

Biological Product (except Diagnostic) Manufacturing

Sector 32 — Manufacturing

Also classified as:
UN ISIC Rev. 4 2100 ≈ EU NACE Rev. 2.1 21.10 ≈ EU NACE Rev. 2.1 21.20 ≈ NA NAICS 2022 325414 AU/NZ ANZSIC 2006 1334 ≈ AU/NZ ANZSIC 2006 1813 ≈ AU/NZ ANZSIC 2006 1841
ISIC ↔ NACE crosswalk → ISIC ↔ NAICS crosswalk → ISIC ↔ ANZSIC crosswalk →

GTIAS Industry Analysis Available

This NAICS code maps to a fully analysed industry with an 81-attribute GTIAS scorecard, risk scenarios, and 42+ strategic frameworks.

View Industry Analysis →

About This Industry

This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

Cross-References. Establishments primarily engaged in--
Manufacturing in-vitro diagnostic substances--are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing; and
Manufacturing pharmaceutical preparations (except biological and in-vitro diagnostic substances)--are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.

ISIC Rev. 4 Equivalent

NAICS 325414 maps to the following ISIC Rev. 4 class:

View the full NAICS ↔ ISIC alignment table →